Zobrazeno 1 - 10
of 265
pro vyhledávání: '"Jae-Young Joung"'
Autor:
Jong-Kwang Kim, Jae-Hun Jung, Dong-Hoon Shin, Hye-Jin You, Seho Cha, Bo-Seul Song, Jae-Young Joung, Weon-Seo Park, Kwang-Pyo Kim, Jae-Kyung Myung
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1877 (2021)
Androgen exerts its functions by binding with an androgen receptor (AR). It can activate many signaling pathways that are important to the progression of castration-resistant prostate cancer (CRPC). Here, we characterized the rapid proteomic changes
Externí odkaz:
https://doaj.org/article/6b7e7550bec8479da890a933ba610b2f
Autor:
Dong Jin Park, Tae Gyun Kwon, Jae Young Park, Jae Young Joung, Hong Koo Ha, Seong Soo Jeon, Sung-Hoo Hong, Sungchan Park, Seung Hwan Lee, Jin Seon Cho, Sung-Woo Park, Se Yun Kwon, Jung Ki Jo, Hong Seok Park, Sang-Cheol Lee, Dong Deuk Kwon, Sun Il Kim, Sang Hyun Park, Soodong Kim, Chang Wook Jeong, Cheol Kwak, Seock Hwan Choi
Publikováno v:
The World Journal of Men's Health, Vol 42, Iss 3, Pp 620-629 (2024)
Purpose: This study aimed to compare the short-term outcomes and safety profiles of androgen-deprivation therapy (ADT)+abiraterone/prednisone with those of ADT+docetaxel in patients with de novo metastatic hormone-sensitive prostate cancer (mHSPC).
Externí odkaz:
https://doaj.org/article/347e0bb0fba64d7ca5219da0a8a24a5a
Autor:
Sung Han Kim, Jae Young Joung, Weon Seo Park, Jongkeun Park, Jin Seok Lee, Boram Park, Dongwan Hong
Publikováno v:
The World Journal of Men's Health, Vol 41, Iss 3, Pp 712-723 (2023)
Purpose: This study aimed to identify metabolic genes associated with non-metastatic prostate cancer progression using The Cancer Genome Atlas (TCGA) datasets and validate their prognostic role by assessing patients’ immunohistochemical prostatect
Externí odkaz:
https://doaj.org/article/c85c5668f00046f894b7462e8a906587
Autor:
Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhang-Qun Ye, Hiroyoshi Suzuki, Taek Won Kang, Da-Lin He, Jae Young Joung, Sabine D Brookman-May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Ding-Wei Ye, Kim N Chi, Hirotsugu Uemura
Publikováno v:
Asian Journal of Andrology, Vol 25, Iss 6, Pp 653-661 (2023)
The final analysis of the phase 3 Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) trial showed improvement in overall survival (OS) and other efficacy endpoints with apalutamide plus androgen deprivation therapy (ADT) versu
Externí odkaz:
https://doaj.org/article/c78d4747b1574342b443336c6734afee
Autor:
Seung Il Jung, Myung Soo Kim, Chang Wook Jeong, Cheol Kwak, Sung Kyu Hong, Seok Ho Kang, Jae Young Joung, Seung Hwan Lee, Seok Joong Yun, Tae-Hwan Kim, Sung Woo Park, Seong Soo Jeon, Minyong Kang, Ji Youl Lee, Byung Ha Chung, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim, Dong Deuk Kwon
Publikováno v:
Investigative and Clinical Urology, Vol 61, Iss 1, Pp 19-27 (2020)
Purpose: This study aimed to evaluate the clinical efficacy of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients using real-world data from Korean patients. Materials and Methods: We retrospectively
Externí odkaz:
https://doaj.org/article/1565b3b41ff54be8a3250dcac6fe247a
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 6, Pp 432-441 (2019)
Purpose: This study aimed to identify prognostic factors for outcomes after radical nephroureterectomy among patients with upper urinary tract urothelial carcinoma (UTUC). Materials and Methods: We retrospectively reviewed 184 nonmetastatic cases of
Externí odkaz:
https://doaj.org/article/34ed6db330964c3c8951d1bd6f1df922
Autor:
Sung Han Kim, Dong-eun Lee, Boram Park, Jungnam Joo, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background The differences in progression-free survival (PFS) and cancer-specific survival (CSS) of metastatic renal cell carcinoma (mRCC) patients according to treatment, type of metastasis, and Heng criteria risk are unclear. In this study
Externí odkaz:
https://doaj.org/article/fac23d7016e4484db109e734b5f22a96
Autor:
Whi-An Kwon, Jae Young Joung, Jung Eun Lee, Se Young Choi, Sung Han Kim, Ho Kyung Seo, Kang Hyun Lee, Choung-Soo Kim
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 3, Pp 195-201 (2019)
Purpose: We aimed to evaluate the efficacy and safety of the use of docetaxel plus androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC) in Korean patients. Materials and Methods: This study was conducted retrosp
Externí odkaz:
https://doaj.org/article/46b896a7784e4e44aea409202ab6f9f5
Autor:
Boram Ha, Kwan Ho Cho, Kang Hyun Lee, Jae Young Joung, Yeon-Joo Kim, Sung Uk Lee, Hyunjung Kim, Yang-Gun Suh, Sung Ho Moon, Young Kyung Lim, Jong Hwi Jeong, Haksoo Kim, Weon Seo Park, Sun Ho Kim
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background We performed a prospective phase II study to compare acute toxicity among five different hypofractionated schedules using proton therapy. This study was an exploratory analysis to investigate the secondary end-point of biochemical
Externí odkaz:
https://doaj.org/article/962069c5540b4b45b0800b81288eba3d
Autor:
Hyung Ho Lee, Andy Jinseok Lee, Weon Seo Park, Jongkeun Lee, Jongkeun Park, Boram Park, Jae Young Joung, Kang Hyun Lee, Dongwan Hong, Sung Han Kim
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundTo evaluate the role of epithelial splicing regulatory protein 1 (ESRP1) expression in survival prognoses and disease progression for prostate cancer (PC) using The Cancer Genome Atlas (TCGA) dataset and to validate it using patients’ pro
Externí odkaz:
https://doaj.org/article/18a7aa9f51b64dcab6753a5f182579ab